Newly identified biomarkers can indicate if the patients with Ebola virus would live or die and also predict the patients who are more at risk.
New biomarkers have been identified that help in predicting the risk of death in Ebola patients. reveals a new study. The results come from scientists at the Department of Energy's Pacific Northwest National Laboratory and their colleagues at the University of Wisconsin-Madison, Icahn School of Medicine at Mount Sinai, the University of Tokyo and the University of Sierra Leone. The results were published online in the journal Cell Host & Microbe.
‘About 11 biomarkers discovered can help distinguish fatal infections and non-fatal infections; and can also predict the risk of death in Ebola patients.’
The findings could allow clinicians to prioritize the scarce treatment resources available and provide them to the sickest patients, said the senior author of the study, Yoshihiro Kawaoka, a virology professor at the UW-Madison School of Veterinary Medicine.The focus of the study were blood samples from Ebola patients that were obtained during the outbreak in Sierra Leone in 2014. The Wisconsin team obtained 29 blood samples from 11 patients who ultimately survived and nine blood samples from nine patients who died from the virus.
The Wisconsin team inactivated the virus according to approved protocols, developed in part at PNNL, and then shipped the samples to PNNL and other institutions for analysis.
The team looked at activity levels of genes and proteins as well as the amounts of lipids and byproducts of metabolism.
The team found 11 biomarkers that distinguish fatal infections from non-fatal ones and two that, when screened for early upon symptom onset, accurately predict which patients are likely to die.
Advertisement
"This may be the most thorough analysis yet of blood samples of patients infected with the Ebola virus."
Advertisement
Fatal cases had unique metabolic responses compared to survivors, higher levels of virus, changes to plasma lipids involved in processes like blood coagulation, and more pronounced activation of some types of immune cells.
Pancreatic enzymes also leaked into the blood of patients who died, suggesting that damage from these enzymes contributes to the tissue damage characteristic of fatal Ebola virus disease.
The scientists found that levels of two biomarkers, known as L-threonine (an amino acid) and vitamin-D-binding-protein, may accurately predict which patients live and which die. Both were present at lower levels at the time of admission in the patients who ultimately perished.
The team found that many of the molecular signals present in the blood of sick, infected patients overlap with sepsis, a condition in which the body in response to infection by bacteria or other pathogens - mounts a damaging inflammatory reaction.
Fifteen PNNL scientists contributed to the study. Among the corresponding authors of the study are three PNNL scientists: Waters, Thomas Metz and Richard D. Smith. Three additional PNNL scientists Jason P. Wendler, Jennifer E. Kyle and Kristin E. Burnum-Johnson are among six scientists who share "first author" honors.
Source-Eurekalert